The influence of Bz-DOTA and CHX-A″-DTPA on the biodistribution of ABD-fused anti-HER2 Affibody molecules: implications for 114m In-mediated targeting therapy

Author： Tolmachev Vladimir  

Publisher： Springer Publishing Company

ISSN： 1619-7070

Source： European Journal of Nuclear Medicine and Molecular Imaging, Vol.36, Iss.9, 2009-09, pp. : 1460-1468

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Influence of valency and labelling chemistry on in vivo targeting using radioiodinated HER2-binding Affibody molecules

By Tolmachev Vladimir  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 36, Iss. 4, 2009-04 ,pp. : 692-701

Springer Publishing Company

Access to resources Recommend Favorite

Development and preclinical characterisation of 99mTc-labelled Affibody molecules with reduced renal uptake

By Ekblad Torun   Tran Thuy   Orlova Anna   Widström Charles   Feldwisch Joachim   Abrahmsén Lars   Wennborg Anders   Karlström Amelie   Tolmachev Vladimir  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 35, Iss. 12, 2008-12 ,pp. : 2245-2255

Springer Publishing Company

Access to resources Recommend Favorite

[18F]FBEM-ZHER2:342–Affibody molecule—a new molecular tracer for in vivo monitoring of HER2 expression by positron emission tomography

By Kramer-Marek Gabriela   Kiesewetter Dale   Martiniova Lucia   Jagoda Elaine   Lee Sang   Capala Jacek  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 35, Iss. 5, 2008-05 ,pp. : 1008-1018

Springer Publishing Company

Access to resources Recommend Favorite

Associations between the uptake of 111In-DTPA-trastuzumab, HER2 density and response to trastuzumab (Herceptin) in athymic mice bearing subcutaneous human tumour xenografts

By McLarty Kristin   Cornelissen Bart   Scollard Deborah   Done Susan   Chun Kathy   Reilly Raymond  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 36, Iss. 1, 2009-01 ,pp. : 81-93

Springer Publishing Company

Access to resources Recommend Favorite

Pre-therapeutic dosimetry and biodistribution of 86Y-DOTA-Phe1-Tyr3-octreotide versus 111In-pentetreotide in patients with advanced neuroendocrine tumours

By Helisch Andreas   Förster Gregor   Reber Helmut   Buchholz Hans-Georg   Arnold Rudolf   Göke Burkhard   Weber Matthias   Wiedenmann Bertram   Pauwels Stanislas   Haus Ulrike   Bouterfa Hakim   Bartenstein Peter  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 31, Iss. 10, 2004-10 ,pp. : 1386-1392

Springer Publishing Company

Access to resources Recommend Favorite